Xcell Biosciences Collaborates Closely with Labcorp for Gene Therapy Advancements

Monday, 1 April 2024, 12:32

Xcell Biosciences solidifies its partnership with Labcorp, granting them an observer seat on the board and bolstering Labcorp's financial commitment. This move signifies a deepening of the collaboration between the two entities towards advancing gene therapy research and innovation in the medical sector. The increased investment from Labcorp highlights a strategic alignment focused on driving impactful developments in gene therapy.
LivaRava Finance Meta Image
Xcell Biosciences Collaborates Closely with Labcorp for Gene Therapy Advancements

Xcell Biosciences & Labcorp Collaboration

Xcell Biosciences and Labcorp have strengthened their partnership, with Labcorp attaining an observer seat on the board. This move aims to enhance the collaboration between the two entities towards advancing gene therapy research.

Increased Investment

Labcorp has raised its investment in Xcell Biosciences, showcasing a commitment to driving innovation in gene therapy.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe